End-organ protection in hypertension by the novel and selective Rho-kinase inhibitor, SAR407899

• 作 者: Matthias L?hn Oliver Plettenbu
• 机 构: TranslationalMedicine
• 出 处: 世界心脏病学杂志：英文版（电子版）
• 发表日期: 2015年1期
• 关键词: HYPERTENSION END ORGAN damage Rhokinase ANGIOTENSIN CONVERTING enzyme-inhibition

AIM: To compare the therapeutic efficacy of SAR407899 with the current standard treatment for hypertension [an angiotensin converting enzyme(ACE)-inhibitor and a calcium channel blocker] and compare the frequency and severity of the hypertension-related e